The relationship between matrix metalloproteinases (MMP-3, -8, -9) in serum and peripheral lymphocytes (CD8+, CD56+) in Down syndrome children with gingivitis
Background and Objective Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis. Material and Methods C...
Uložené v:
| Vydané v: | Journal of periodontal research Ročník 49; číslo 6; s. 742 - 750 |
|---|---|
| Hlavní autori: | , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Blackwell Publishing Ltd
01.12.2014
|
| Predmet: | |
| ISSN: | 0022-3484, 1600-0765, 1600-0765 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background and Objective
Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis.
Material and Methods
Children with Down syndrome (n = 10) and healthy controls (n = 10) were clinically and radiographically examined during dental treatment under general anaesthesia. Peripheral blood and gingival crevicular fluid were collected from each subject and concentrations were determined: serum MMP‐2, ‐3, ‐8 and ‐9; serum tissue inhibitors of metalloproteinases (TIMP) ‐1, ‐2 and ‐3; and gingival crevicular fluid. Leukocytes were isolated from peripheral blood and the relative amounts (%) of the various cell phenotypes were analysed using flow cytometry. In addition, peripheral blood cells were treated with Porphyromonas gingivalis lipopolysaccharide and levels of MMPs and TIMPs measured.
Results
Concentrations of MMP‐3, MMP‐8 and TIMP‐1 in serum were significantly higher (p < 0.05) in the Down syndrome group compared to the controls. When peripheral blood leukocytes were cultured in the presence or absence of P. gingivalis lipopolysaccharide, MMP‐8 levels were significantly (p < 0.05) higher in the Down syndrome group compared to controls. Children with Down syndrome exhibited significant positive correlations between CD8+ T cells and MMP‐8 (r = 0.630; p = 0.050), between CD8+ T cells and MMP‐9 (r = 0.648; p = 0.043), and between CD56+ NK cells and MMP‐3 (r = 0.828; p = 0.003) compared to controls.
Conclusions
The positive relationship of serum MMP‐3, ‐8 and ‐9 with immune cells in children with Down syndrome may facilitate migration of CD8+ T cells and CD56+ NK cells into the periodontal tissue, which may contribute to the increased degradation of periodontal tissue in individuals with Down syndrome. |
|---|---|
| AbstractList | Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis.BACKGROUND AND OBJECTIVEAltered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis.Children with Down syndrome (n = 10) and healthy controls (n = 10) were clinically and radiographically examined during dental treatment under general anaesthesia. Peripheral blood and gingival crevicular fluid were collected from each subject and concentrations were determined: serum MMP-2, -3, -8 and -9; serum tissue inhibitors of metalloproteinases (TIMP) -1, -2 and -3; and gingival crevicular fluid. Leukocytes were isolated from peripheral blood and the relative amounts (%) of the various cell phenotypes were analysed using flow cytometry. In addition, peripheral blood cells were treated with Porphyromonas gingivalis lipopolysaccharide and levels of MMPs and TIMPs measured.MATERIAL AND METHODSChildren with Down syndrome (n = 10) and healthy controls (n = 10) were clinically and radiographically examined during dental treatment under general anaesthesia. Peripheral blood and gingival crevicular fluid were collected from each subject and concentrations were determined: serum MMP-2, -3, -8 and -9; serum tissue inhibitors of metalloproteinases (TIMP) -1, -2 and -3; and gingival crevicular fluid. Leukocytes were isolated from peripheral blood and the relative amounts (%) of the various cell phenotypes were analysed using flow cytometry. In addition, peripheral blood cells were treated with Porphyromonas gingivalis lipopolysaccharide and levels of MMPs and TIMPs measured.Concentrations of MMP-3, MMP-8 and TIMP-1 in serum were significantly higher (p < 0.05) in the Down syndrome group compared to the controls. When peripheral blood leukocytes were cultured in the presence or absence of P. gingivalis lipopolysaccharide, MMP-8 levels were significantly (p < 0.05) higher in the Down syndrome group compared to controls. Children with Down syndrome exhibited significant positive correlations between CD8(+) T cells and MMP-8 (r = 0.630; p = 0.050), between CD8(+) T cells and MMP-9 (r = 0.648; p = 0.043), and between CD56(+) NK cells and MMP-3 (r = 0.828; p = 0.003) compared to controls.RESULTSConcentrations of MMP-3, MMP-8 and TIMP-1 in serum were significantly higher (p < 0.05) in the Down syndrome group compared to the controls. When peripheral blood leukocytes were cultured in the presence or absence of P. gingivalis lipopolysaccharide, MMP-8 levels were significantly (p < 0.05) higher in the Down syndrome group compared to controls. Children with Down syndrome exhibited significant positive correlations between CD8(+) T cells and MMP-8 (r = 0.630; p = 0.050), between CD8(+) T cells and MMP-9 (r = 0.648; p = 0.043), and between CD56(+) NK cells and MMP-3 (r = 0.828; p = 0.003) compared to controls.The positive relationship of serum MMP-3, -8 and -9 with immune cells in children with Down syndrome may facilitate migration of CD8(+) T cells and CD56(+) NK cells into the periodontal tissue, which may contribute to the increased degradation of periodontal tissue in individuals with Down syndrome.CONCLUSIONSThe positive relationship of serum MMP-3, -8 and -9 with immune cells in children with Down syndrome may facilitate migration of CD8(+) T cells and CD56(+) NK cells into the periodontal tissue, which may contribute to the increased degradation of periodontal tissue in individuals with Down syndrome. Background and Objective Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis. Material and Methods Children with Down syndrome (n = 10) and healthy controls (n = 10) were clinically and radiographically examined during dental treatment under general anaesthesia. Peripheral blood and gingival crevicular fluid were collected from each subject and concentrations were determined: serum MMP‐2, ‐3, ‐8 and ‐9; serum tissue inhibitors of metalloproteinases (TIMP) ‐1, ‐2 and ‐3; and gingival crevicular fluid. Leukocytes were isolated from peripheral blood and the relative amounts (%) of the various cell phenotypes were analysed using flow cytometry. In addition, peripheral blood cells were treated with Porphyromonas gingivalis lipopolysaccharide and levels of MMPs and TIMPs measured. Results Concentrations of MMP‐3, MMP‐8 and TIMP‐1 in serum were significantly higher (p < 0.05) in the Down syndrome group compared to the controls. When peripheral blood leukocytes were cultured in the presence or absence of P. gingivalis lipopolysaccharide, MMP‐8 levels were significantly (p < 0.05) higher in the Down syndrome group compared to controls. Children with Down syndrome exhibited significant positive correlations between CD8+ T cells and MMP‐8 (r = 0.630; p = 0.050), between CD8+ T cells and MMP‐9 (r = 0.648; p = 0.043), and between CD56+ NK cells and MMP‐3 (r = 0.828; p = 0.003) compared to controls. Conclusions The positive relationship of serum MMP‐3, ‐8 and ‐9 with immune cells in children with Down syndrome may facilitate migration of CD8+ T cells and CD56+ NK cells into the periodontal tissue, which may contribute to the increased degradation of periodontal tissue in individuals with Down syndrome. Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis. Children with Down syndrome (n = 10) and healthy controls (n = 10) were clinically and radiographically examined during dental treatment under general anaesthesia. Peripheral blood and gingival crevicular fluid were collected from each subject and concentrations were determined: serum MMP-2, -3, -8 and -9; serum tissue inhibitors of metalloproteinases (TIMP) -1, -2 and -3; and gingival crevicular fluid. Leukocytes were isolated from peripheral blood and the relative amounts (%) of the various cell phenotypes were analysed using flow cytometry. In addition, peripheral blood cells were treated with Porphyromonas gingivalis lipopolysaccharide and levels of MMPs and TIMPs measured. Concentrations of MMP-3, MMP-8 and TIMP-1 in serum were significantly higher (p<0.05) in the Down syndrome group compared to the controls. When peripheral blood leukocytes were cultured in the presence or absence of P. gingivalis lipopolysaccharide, MMP-8 levels were significantly (p<0.05) higher in the Down syndrome group compared to controls. Children with Down syndrome exhibited significant positive correlations between CD8+ T cells and MMP-8 (r = 0.630; p=0.050), between CD8+ T cells and MMP-9 (r = 0.648; p=0.043), and between CD56+NK cells and MMP-3 (r = 0.828; p =0.003) compared to controls. The positive relationship of serum MMP-3, -8 and -9 with immune cells in children with Down syndrome may facilitate migration of CD8+ T cells and CD56+NK cells into the periodontal tissue, which may contribute to the increased degradation of periodontal tissue in individuals with Down syndrome. Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral lymphocytes and matrix metalloproteinases (MMPs) in serum in Down syndrome children with gingivitis. Children with Down syndrome (n = 10) and healthy controls (n = 10) were clinically and radiographically examined during dental treatment under general anaesthesia. Peripheral blood and gingival crevicular fluid were collected from each subject and concentrations were determined: serum MMP-2, -3, -8 and -9; serum tissue inhibitors of metalloproteinases (TIMP) -1, -2 and -3; and gingival crevicular fluid. Leukocytes were isolated from peripheral blood and the relative amounts (%) of the various cell phenotypes were analysed using flow cytometry. In addition, peripheral blood cells were treated with Porphyromonas gingivalis lipopolysaccharide and levels of MMPs and TIMPs measured. Concentrations of MMP-3, MMP-8 and TIMP-1 in serum were significantly higher (p < 0.05) in the Down syndrome group compared to the controls. When peripheral blood leukocytes were cultured in the presence or absence of P. gingivalis lipopolysaccharide, MMP-8 levels were significantly (p < 0.05) higher in the Down syndrome group compared to controls. Children with Down syndrome exhibited significant positive correlations between CD8(+) T cells and MMP-8 (r = 0.630; p = 0.050), between CD8(+) T cells and MMP-9 (r = 0.648; p = 0.043), and between CD56(+) NK cells and MMP-3 (r = 0.828; p = 0.003) compared to controls. The positive relationship of serum MMP-3, -8 and -9 with immune cells in children with Down syndrome may facilitate migration of CD8(+) T cells and CD56(+) NK cells into the periodontal tissue, which may contribute to the increased degradation of periodontal tissue in individuals with Down syndrome. |
| Author | Concha Quezada, H. Yucel-Lindberg, T. Modéer, T. Tsilingaridis, G. |
| Author_xml | – sequence: 1 givenname: G. surname: Tsilingaridis fullname: Tsilingaridis, G. email: georgios.tsilingaridis@ki.se organization: Division of Paediatric Dentistry, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden – sequence: 2 givenname: T. surname: Yucel-Lindberg fullname: Yucel-Lindberg, T. organization: Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Sweden, Huddinge – sequence: 3 givenname: H. surname: Concha Quezada fullname: Concha Quezada, H. organization: Center for Infectious Medicine, Department of Medicine, Karolinska University Hospital, Huddinge, Sweden – sequence: 4 givenname: T. surname: Modéer fullname: Modéer, T. organization: Division of Paediatric Dentistry, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24372339$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:130160255$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNqNksluFDEQhi0URCaBAy-AfEyUdOKluz19jGaygDKAUFjExXK7a9JO3Au2m8m8DM-KM0sOCCQsWS5b319l_VV7aKftWkDoNSUnNK7TOwcnlNFMPEMjmhOSEJFnO2hECGMJT8fpLtrz_o7Eey6KF2iXpVwwzosR-nVTA3ZgVTBd62vT4xLCAqDFjQrOPOAGgrK2610XwLTKg8cHs9nHhB_jZBx3cYhNiz24ocGqrXAPzvQ1OGWxXTZ93elleNRMpuOjYzyZZvnRSjHtFlG2bCvXNYB1bWzlYtWFCTW-Ne2t-WmC8S_R87myHl5tzn30-eL8ZnKVXH-4fDs5u040TwuRRBOKSuV5RcWcCa6qshIlKzXJKgYEynmZjUulKUmzNNeFhgxYKbjQ8yJPS6r5PkrWef0C-qGUvTONckvZKSM3T_cxApmxVFAe-YM1H335MYAPsjFeg7WqhW7wkuax0DjNBPkPlDGSp5SziL7ZoEPZQPX0i227InC6BrTrvHcwl9qEVeuCU8ZKSuTjQMg4EHI1EFFx-Idim_Rv7Cb7wlhY_huU7z6dbxUb24wP8PCkUO5e5tHeTH59fyn5jH_5dnFF5Hf-G2Ra044 |
| CitedBy_id | crossref_primary_10_1016_j_cyto_2025_156910 crossref_primary_10_1007_s12602_025_10511_8 crossref_primary_10_3390_dj13010033 crossref_primary_10_1007_s00784_024_05789_x crossref_primary_10_1186_s12964_021_00705_2 crossref_primary_10_1080_19932820_2022_2116794 crossref_primary_10_1016_j_cden_2016_02_003 crossref_primary_10_1111_jre_12533 crossref_primary_10_1111_jir_12553 crossref_primary_10_1002_jcla_25002 crossref_primary_10_1002_JPER_16_0480 crossref_primary_10_3390_ijms22126274 crossref_primary_10_1111_prd_12487 crossref_primary_10_3390_genes16020122 crossref_primary_10_1111_jcpe_12947 |
| Cites_doi | 10.1902/jop.1996.67.8.748 10.1177/154405910608501202 10.1007/s00784-010-0495-6 10.1111/j.1600-0757.1997.tb00195.x 10.4049/jimmunol.164.4.2102 10.4049/jimmunol.156.1.160 10.1016/j.ijcard.2011.12.095 10.1007/s12026-009-8098-5 10.3109/00016359709115400 10.4049/jimmunol.149.7.2506 10.1902/jop.2001.72.10.1398 10.1161/01.RES.0000070112.80711.3D 10.1096/fasebj.9.14.7589989 10.1016/0167-4889(93)90037-P 10.1111/j.1600-051X.1989.tb01659.x 10.1080/00016350310002270 10.1111/j.1399-302X.1992.tb00033.x 10.1002/ajmg.1320370742 10.1902/jop.1986.57.5.288 10.1001/archpedi.160.9.894 10.1016/S0952-7915(98)80227-6 10.1111/j.1744-313X.2010.00914.x 10.1080/00016350600963640 10.1111/j.1365-2788.1993.tb00324.x 10.1111/j.1600-0765.1989.tb02000.x 10.1016/j.cardiores.2005.12.002 10.1016/j.jpeds.2005.07.022 10.1034/j.1600-0722.2002.21247.x 10.1111/j.1600-051X.1993.tb00328.x 10.1016/j.phrs.2010.10.005 10.1111/j.1600-0765.2009.01214.x 10.4049/jimmunol.158.5.2327 10.1111/j.1600-051X.2005.00737.x 10.1080/07853890600800103 10.1111/jre.12038 10.1016/S0361-9230(01)00476-2 10.1177/154405910708600509 10.1111/j.1651-2227.1995.tb13768.x 10.1111/j.1600-051X.1986.tb01416.x 10.1182/blood-2008-05-078154 10.1146/annurev.immunol.021908.132710 10.1242/jcs.00063 10.4049/jimmunol.156.1.1 10.1902/jop.2000.71.7.1079 10.1002/jcp.1041570326 10.1002/ajmg.1320370743 10.1021/bi960036x 10.1111/j.1601-0825.2006.01323.x 10.1111/j.1365-2249.1996.tb08297.x 10.1016/j.phrs.2011.06.019 |
| ContentType | Journal Article |
| Copyright | 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
| Copyright_xml | – notice: 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd – notice: 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 ADTPV AOWAS |
| DOI | 10.1111/jre.12157 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts SwePub SwePub Articles |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
| DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Dentistry |
| EISSN | 1600-0765 |
| EndPage | 750 |
| ExternalDocumentID | oai_swepub_ki_se_524713 24372339 10_1111_jre_12157 JRE12157 ark_67375_WNG_3M3VXFH0_Z |
| Genre | article Journal Article Comparative Study |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29L 31~ 33P 34H 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CWXXS D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.T H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WBNRW WIH WIJ WIK WOHZO WPGGZ WQJ WXSBR XG1 YFH ZGI ZZTAW ~IA ~WT AAYXX CITATION O8X AAHHS ACCFJ AEEZP AEQDE AIWBW AJBDE ALUQN CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 ADTPV AOWAS |
| ID | FETCH-LOGICAL-c3497-1119da66d17f273adbd7b2bc05d2e0ebfb58bac104546c9ce5e2b737cf964b1c3 |
| IEDL.DBID | DRFUL |
| ISSN | 0022-3484 1600-0765 |
| IngestDate | Tue Nov 25 03:29:25 EST 2025 Fri Jul 11 15:53:58 EDT 2025 Fri Jul 11 10:13:16 EDT 2025 Thu Apr 03 07:08:41 EDT 2025 Sat Nov 29 06:41:56 EST 2025 Tue Nov 18 21:53:41 EST 2025 Tue Nov 11 03:13:55 EST 2025 Tue Nov 11 03:30:48 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | crevicular fluid Down syndrome T cells serum matrix metalloproteinases |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3497-1119da66d17f273adbd7b2bc05d2e0ebfb58bac104546c9ce5e2b737cf964b1c3 |
| Notes | istex:6C29E950428EE166A1E6D119ED453DA80EB7A611 ArticleID:JRE12157 ark:/67375/WNG-3M3VXFH0-Z ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
| PMID | 24372339 |
| PQID | 1622064132 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_524713 proquest_miscellaneous_1654684570 proquest_miscellaneous_1622064132 pubmed_primary_24372339 crossref_citationtrail_10_1111_jre_12157 crossref_primary_10_1111_jre_12157 wiley_primary_10_1111_jre_12157_JRE12157 istex_primary_ark_67375_WNG_3M3VXFH0_Z |
| PublicationCentury | 2000 |
| PublicationDate | December 2014 |
| PublicationDateYYYYMMDD | 2014-12-01 |
| PublicationDate_xml | – month: 12 year: 2014 text: December 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Journal of periodontal research |
| PublicationTitleAlternate | J Periodont Res |
| PublicationYear | 2014 |
| Publisher | Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Ltd |
| References | Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998;10:581-587. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839. Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet 2010;37:233-237. Murphy M, Friend DS, Pike-Nobile L, Epstein LB. Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21). J Immunol 1992;149:2506-2512. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008;112:1557-1569. Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol 1993;157:644-649. Tsilingaridis G, Yucel-Lindberg T, Modeer T. T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome. Clin Oral Investig 2012;16:267-273. Lauhio A, Hastbacka J, Pettila V et al. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011;64:590-594. Barr-Agholme M, Dahllof G, Linder L, Modeer T. Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome. Oral Microbiol Immunol 1992;7:244-248. Tsilingaridis G, Yucel-Lindberg T, Modeer T. Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 2003;61:154-158. Pueschel SM, Anneren G, Durlach R, Flores J, Sustrova M, Verma IC. Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH). Acta Paediatr 1995;84:823-827. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249. Cossarizza A, Monti D, Montagnani G et al. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl 1990;7:213-218. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002;115:3719-3727. Kinane DF, Johnston FA, Evans CW. Depressed helper-to-suppressor T-cell ratios in early-onset forms of periodontal disease. J Periodontal Res 1989;24:161-164. Colombo ML, Girardo E, Saitta M, Ricci BM, Maina D. [The immunological profile of children with Down's syndrome]. Minerva Pediatr 1989;41:1-4. Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunological features of Down's syndrome: a review. J Intellect Disabil Res 1993;6:543-551. Zeng L, An S, Goetzl EJ. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Biochemistry 1996;35:7159-7164. Pussinen PJ, Sarna S, Puolakkainen M, Ohlin H, Sorsa T, Pesonen E. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol 2013;167:362-368. Seguier S, Godeau G, Brousse N. Collagen fibers and inflammatory cells in healthy and diseased human gingival tissues: a comparative and quantitative study by immunohistochemistry and automated image analysis. J Periodontol 2000;71:1079-1085. Lejeune J, Turpin R, Gautier M. [Mongolism; a chromosomal disease (trisomy)]. Bull Acad Natl Med 1959;143:256-265. Domeij H, Yucel-Lindberg T, Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 2002;110:302-306. Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000;164:2102-2109. Chaves ES, Wood RC, Jones AA, Newbold DA, Manwell MA, Kornman KS. Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. J Clin Periodontol 1993;20:139-143. Halinen S, Sorsa T, Ding Y et al. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol 1996;67:748-754. Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 2006;85:1074-1084. Johnatty RN, Taub DD, Reeder SP et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997;158:2327-2333. Zhou H, Bernhard EJ, Fox FE, Billings PC. Induction of metalloproteinase activity in human T-lymphocytes. Biochim Biophys Acta 1993;1177:174-178. Kallestal C, Matsson L. Criteria for assessment of interproximal bone loss on bite-wing radiographs in adolescents. J Clin Periodontol 1989;16:300-304. Barkin RM, Weston WL, Humbert JR, Sunada K. Phagocytic function in Down syndrome - II. Bactericidal activity and phagocytosis. J Ment Defic Res 1980;4:251-256. Mazzoni A, Mannello F, Tay FR et al. Zymographic analysis and characterization of MMP-2 and -9 forms in human sound dentin. J Dent Res 2007;86:436-440. Barr-Agholme M, Krekmanova L, Yucel-Lindberg T, Shinoda K, Modeer T. Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 1997;55:101-105. Sorsa T, Tervahartiala T, Leppilahti J et al. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 2011;63:108-113. Barkin RM, Weston WL, Humbert JR, Maire F. Phagocytic function in Down syndrome - I. Chemotaxis. J Ment Defic Res 1980;4:243-249. Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down syndrome: a review. Am J Med Genet Suppl 1990;7:204-212. Licastro F, Mariani RA, Faldella G et al. Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency. Brain Res Bull 2001;55:313-317. Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 2007;65:1-13. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4. Sakellari D, Arapostathis KN, Konstantinidis A. Periodontal conditions and subgingival microflora in Down syndrome patients. A case-control study. J Clin Periodontol 2005;32:684-690. Mosmann TR, Kobie JJ, Lee FE, Quataert SA. T helper cytokine patterns: defined subsets, random expression, and external modulation. Immunol Res 2009;45:173-184. Seguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001;72:1398-1406. Tsilingaridis G, Yucel-Lindberg T, Modeer T. Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome. J Periodontal Res 2013;48:553-562. Yamazaki-Kubota T, Miyamoto M, Sano Y et al. Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down's syndrome. J Periodontal Res 2010;45:170-176. Levin S. The immune system and susceptibility to infections in Down's syndrome. Prog Clin Biol Res 1987;246:143-162. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517. Weeks BS. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review). Int J Mol Med 1998;1:361-366. Reuland-Bosma W, van Dijk J. Periodontal disease in Down's syndrome: a review. J Clin Periodontol 1986;13:64-73. Sorsa T, Tjaderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321. Karttunen R, Nurmi T, Ilonen J, Surcel HM. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets. Clin Exp Immunol 1984;55:257-263. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573. Leppert D, Hauser SL, Kishiyama JL, An S, Zeng L, Goetzl EJ. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J 1995;9:1473-1481. Restaino CG, Chaparro A, Valenzuela MA et al. Stimulatory response of neutrophils from periodontitis patients with periodontal pathogens. Oral Dis 2007;13:474-481. Xia M, Leppert D, Hauser SL et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996;156:160-167. Modeer T, Barr M, Dahllof G. Periodontal disease in children with Down's syndrome. Scand J Dent Res 1990;98:228-234. Murphy M, Lempert MJ, Epstein LB. Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet Suppl 1990;7:234-237. de Hingh YC, van der Vossen PW, Gemen EF et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005;147:744-747. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997;14:144-157. Reeves AF, Rees JM, Schiff M, Hujoel P. Total body weight and waist circumference associated with chronic periodontitis among adolescents in the United States. Arch Pediatr Adolesc Med 2006;160:894-899. Barnett ML, Press KP, Friedman D, Sonnenberg EM. The prevalence of periodontitis 2009; 45 1989; 41 1997; 158 1990; 98 2002; 110 2006; 38 1993; 20 2013; 167 2002; 115 2012; 16 1996; 35 1996; 103 1993; 6 1992; 7 1976; 34 2003; 92 1997; 55 2005; 147 1984; 55 1997; 14 2006; 69 2011; 64 2011; 63 2005; 32 2000; 164 2006; 160 2001; 55 2008; 112 2007; 65 1998; 10 1996; 67 1995; 9 2001; 72 2013; 48 2010; 37 1959; 143 1987; 246 1986; 13 1986; 57 1992; 149 1993; 1177 2000; 71 1989; 24 2009; 27 2007; 13 2010; 45 1995; 84 2006; 85 1980; 4 1998; 1 2007; 86 2003; 61 1993; 157 1989; 16 1996; 156 1990; 7 e_1_2_5_27_1 e_1_2_5_25_1 e_1_2_5_48_1 e_1_2_5_46_1 e_1_2_5_21_1 e_1_2_5_44_1 Murphy M (e_1_2_5_19_1) 1992; 149 Colombo ML (e_1_2_5_22_1) 1989; 41 e_1_2_5_29_1 e_1_2_5_61_1 e_1_2_5_42_1 Nespoli L (e_1_2_5_31_1) 1993; 6 e_1_2_5_40_1 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_36_1 e_1_2_5_59_1 e_1_2_5_9_1 e_1_2_5_11_1 e_1_2_5_57_1 e_1_2_5_7_1 e_1_2_5_13_1 e_1_2_5_32_1 e_1_2_5_55_1 e_1_2_5_5_1 Karttunen R (e_1_2_5_23_1) 1984; 55 Xia M (e_1_2_5_37_1) 1996; 156 Barkin RM (e_1_2_5_17_1) 1980; 4 Weeks BS (e_1_2_5_53_1) 1998; 1 e_1_2_5_30_1 e_1_2_5_51_1 e_1_2_5_28_1 e_1_2_5_49_1 e_1_2_5_26_1 e_1_2_5_47_1 Barkin RM (e_1_2_5_16_1) 1980; 4 e_1_2_5_24_1 e_1_2_5_45_1 e_1_2_5_43_1 Modeer T (e_1_2_5_3_1) 1990; 98 e_1_2_5_60_1 Lejeune J (e_1_2_5_2_1) 1959; 143 e_1_2_5_41_1 e_1_2_5_14_1 e_1_2_5_39_1 e_1_2_5_58_1 e_1_2_5_8_1 Murphy M (e_1_2_5_20_1) 1990; 7 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_56_1 e_1_2_5_6_1 e_1_2_5_12_1 e_1_2_5_33_1 e_1_2_5_4_1 Page RC (e_1_2_5_54_1) 1976; 34 Johnatty RN (e_1_2_5_34_1) 1997; 158 Levin S (e_1_2_5_18_1) 1987; 246 e_1_2_5_52_1 e_1_2_5_50_1 |
| References_xml | – reference: Cossarizza A, Monti D, Montagnani G et al. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl 1990;7:213-218. – reference: Yamazaki-Kubota T, Miyamoto M, Sano Y et al. Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down's syndrome. J Periodontal Res 2010;45:170-176. – reference: Sorsa T, Tervahartiala T, Leppilahti J et al. Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines. Pharmacol Res 2011;63:108-113. – reference: Murphy M, Friend DS, Pike-Nobile L, Epstein LB. Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21). J Immunol 1992;149:2506-2512. – reference: Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997;14:144-157. – reference: Zeng L, An S, Goetzl EJ. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Biochemistry 1996;35:7159-7164. – reference: Tsilingaridis G, Yucel-Lindberg T, Modeer T. T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome. Clin Oral Investig 2012;16:267-273. – reference: Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573. – reference: Barnett ML, Press KP, Friedman D, Sonnenberg EM. The prevalence of periodontitis and dental caries in a Down's syndrome population. J Periodontol 1986;57:288-293. – reference: Pussinen PJ, Sarna S, Puolakkainen M, Ohlin H, Sorsa T, Pesonen E. The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol 2013;167:362-368. – reference: Nespoli L, Burgio GR, Ugazio AG, Maccario R. Immunological features of Down's syndrome: a review. J Intellect Disabil Res 1993;6:543-551. – reference: Barkin RM, Weston WL, Humbert JR, Maire F. Phagocytic function in Down syndrome - I. Chemotaxis. J Ment Defic Res 1980;4:243-249. – reference: Mosmann TR, Kobie JJ, Lee FE, Quataert SA. T helper cytokine patterns: defined subsets, random expression, and external modulation. Immunol Res 2009;45:173-184. – reference: Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485-517. – reference: Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008;112:1557-1569. – reference: Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92:827-839. – reference: Levin S. The immune system and susceptibility to infections in Down's syndrome. Prog Clin Biol Res 1987;246:143-162. – reference: Mazzoni A, Mannello F, Tay FR et al. Zymographic analysis and characterization of MMP-2 and -9 forms in human sound dentin. J Dent Res 2007;86:436-440. – reference: Lejeune J, Turpin R, Gautier M. [Mongolism; a chromosomal disease (trisomy)]. Bull Acad Natl Med 1959;143:256-265. – reference: Weeks BS. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review). Int J Mol Med 1998;1:361-366. – reference: Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol 1993;157:644-649. – reference: Verstappen J, Von den Hoff JW. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 2006;85:1074-1084. – reference: Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000;164:2102-2109. – reference: de Hingh YC, van der Vossen PW, Gemen EF et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005;147:744-747. – reference: Seguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001;72:1398-1406. – reference: Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of Down syndrome: a review. Am J Med Genet Suppl 1990;7:204-212. – reference: Lauhio A, Hastbacka J, Pettila V et al. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol Res 2011;64:590-594. – reference: Kinane DF, Johnston FA, Evans CW. Depressed helper-to-suppressor T-cell ratios in early-onset forms of periodontal disease. J Periodontal Res 1989;24:161-164. – reference: Pueschel SM, Anneren G, Durlach R, Flores J, Sustrova M, Verma IC. Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH). Acta Paediatr 1995;84:823-827. – reference: Sakellari D, Arapostathis KN, Konstantinidis A. Periodontal conditions and subgingival microflora in Down syndrome patients. A case-control study. J Clin Periodontol 2005;32:684-690. – reference: Halinen S, Sorsa T, Ding Y et al. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol 1996;67:748-754. – reference: Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 2007;65:1-13. – reference: Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 2002;115:3719-3727. – reference: Xia M, Leppert D, Hauser SL et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996;156:160-167. – reference: Barr-Agholme M, Krekmanova L, Yucel-Lindberg T, Shinoda K, Modeer T. Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 1997;55:101-105. – reference: Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4. – reference: Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 1996;103:422-428. – reference: Kallestal C, Matsson L. Criteria for assessment of interproximal bone loss on bite-wing radiographs in adolescents. J Clin Periodontol 1989;16:300-304. – reference: Colombo ML, Girardo E, Saitta M, Ricci BM, Maina D. [The immunological profile of children with Down's syndrome]. Minerva Pediatr 1989;41:1-4. – reference: Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet 2010;37:233-237. – reference: Chaves ES, Wood RC, Jones AA, Newbold DA, Manwell MA, Kornman KS. Relationship of "bleeding on probing" and "gingival index bleeding" as clinical parameters of gingival inflammation. J Clin Periodontol 1993;20:139-143. – reference: Reeves AF, Rees JM, Schiff M, Hujoel P. Total body weight and waist circumference associated with chronic periodontitis among adolescents in the United States. Arch Pediatr Adolesc Med 2006;160:894-899. – reference: Leppert D, Hauser SL, Kishiyama JL, An S, Zeng L, Goetzl EJ. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J 1995;9:1473-1481. – reference: Domeij H, Yucel-Lindberg T, Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 2002;110:302-306. – reference: Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249. – reference: Licastro F, Mariani RA, Faldella G et al. Immune-endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency. Brain Res Bull 2001;55:313-317. – reference: Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 1998;10:581-587. – reference: Sorsa T, Tjaderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006;38:306-321. – reference: Barr-Agholme M, Dahllof G, Linder L, Modeer T. Actinobacillus actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of adolescents with Down's syndrome. Oral Microbiol Immunol 1992;7:244-248. – reference: Barkin RM, Weston WL, Humbert JR, Sunada K. Phagocytic function in Down syndrome - II. Bactericidal activity and phagocytosis. J Ment Defic Res 1980;4:251-256. – reference: Tsilingaridis G, Yucel-Lindberg T, Modeer T. Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome. J Periodontal Res 2013;48:553-562. – reference: Karttunen R, Nurmi T, Ilonen J, Surcel HM. Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets. Clin Exp Immunol 1984;55:257-263. – reference: Tsilingaridis G, Yucel-Lindberg T, Modeer T. Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase-9 in gingival crevicular fluid from patients with Down syndrome. Acta Odontol Scand 2003;61:154-158. – reference: Modeer T, Barr M, Dahllof G. Periodontal disease in children with Down's syndrome. Scand J Dent Res 1990;98:228-234. – reference: Restaino CG, Chaparro A, Valenzuela MA et al. Stimulatory response of neutrophils from periodontitis patients with periodontal pathogens. Oral Dis 2007;13:474-481. – reference: Johnatty RN, Taub DD, Reeder SP et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997;158:2327-2333. – reference: Seguier S, Godeau G, Brousse N. Collagen fibers and inflammatory cells in healthy and diseased human gingival tissues: a comparative and quantitative study by immunohistochemistry and automated image analysis. J Periodontol 2000;71:1079-1085. – reference: Reuland-Bosma W, van Dijk J. Periodontal disease in Down's syndrome: a review. J Clin Periodontol 1986;13:64-73. – reference: Murphy M, Lempert MJ, Epstein LB. Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes. Am J Med Genet Suppl 1990;7:234-237. – reference: Zhou H, Bernhard EJ, Fox FE, Billings PC. Induction of metalloproteinase activity in human T-lymphocytes. Biochim Biophys Acta 1993;1177:174-178. – volume: 45 start-page: 173 year: 2009 end-page: 184 article-title: T helper cytokine patterns: defined subsets, random expression, and external modulation publication-title: Immunol Res – volume: 64 start-page: 590 year: 2011 end-page: 594 article-title: Serum MMP‐8, ‐9 and TIMP‐1 in sepsis: high serum levels of MMP‐8 and TIMP‐1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines publication-title: Pharmacol Res – volume: 65 start-page: 1 year: 2007 end-page: 13 article-title: The role of matrix metalloproteinases in the oral environment publication-title: Acta Odontol Scand – volume: 72 start-page: 1398 year: 2001 end-page: 1406 article-title: Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? publication-title: J Periodontol – volume: 85 start-page: 1074 year: 2006 end-page: 1084 article-title: Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease publication-title: J Dent Res – volume: 156 start-page: 160 year: 1996 end-page: 167 article-title: Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane publication-title: J Immunol – volume: 86 start-page: 436 year: 2007 end-page: 440 article-title: Zymographic analysis and characterization of MMP‐2 and ‐9 forms in human sound dentin publication-title: J Dent Res – volume: 98 start-page: 228 year: 1990 end-page: 234 article-title: Periodontal disease in children with Down's syndrome publication-title: Scand J Dent Res – volume: 157 start-page: 644 year: 1993 end-page: 649 article-title: Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B) publication-title: J Cell Physiol – volume: 55 start-page: 101 year: 1997 end-page: 105 article-title: Prostaglandin E2 level in gingival crevicular fluid from patients with Down syndrome publication-title: Acta Odontol Scand – volume: 10 start-page: 581 year: 1998 end-page: 587 article-title: How do cytotoxic lymphocytes kill their targets? publication-title: Curr Opin Immunol – volume: 84 start-page: 823 year: 1995 end-page: 827 article-title: Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH) publication-title: Acta Paediatr – volume: 55 start-page: 257 year: 1984 end-page: 263 article-title: Cell‐mediated immunodeficiency in Down's syndrome: normal IL‐2 production but inverted ratio of T cell subsets publication-title: Clin Exp Immunol – volume: 13 start-page: 474 year: 2007 end-page: 481 article-title: Stimulatory response of neutrophils from periodontitis patients with periodontal pathogens publication-title: Oral Dis – volume: 6 start-page: 543 year: 1993 end-page: 551 article-title: Immunological features of Down's syndrome: a review publication-title: J Intellect Disabil Res – volume: 110 start-page: 302 year: 2002 end-page: 306 article-title: Signal pathways involved in the production of MMP‐1 and MMP‐3 in human gingival fibroblasts publication-title: Eur J Oral Sci – volume: 1177 start-page: 174 year: 1993 end-page: 178 article-title: Induction of metalloproteinase activity in human T‐lymphocytes publication-title: Biochim Biophys Acta – volume: 55 start-page: 313 year: 2001 end-page: 317 article-title: Immune‐endocrine status and coeliac disease in children with Down's syndrome: relationships with zinc and cognitive efficiency publication-title: Brain Res Bull – volume: 27 start-page: 485 year: 2009 end-page: 517 article-title: IL‐17 and Th17 Cells publication-title: Annu Rev Immunol – volume: 20 start-page: 139 year: 1993 end-page: 143 article-title: Relationship of “bleeding on probing” and “gingival index bleeding” as clinical parameters of gingival inflammation publication-title: J Clin Periodontol – volume: 14 start-page: 144 year: 1997 end-page: 157 article-title: Mechanisms of connective tissue matrix destruction in periodontitis publication-title: Periodontol 2000 – volume: 61 start-page: 154 year: 2003 end-page: 158 article-title: Enhanced levels of prostaglandin E2, leukotriene B4, and matrix metalloproteinase‐9 in gingival crevicular fluid from patients with Down syndrome publication-title: Acta Odontol Scand – volume: 158 start-page: 2327 year: 1997 end-page: 2333 article-title: Cytokine and chemokine regulation of proMMP‐9 and TIMP‐1 production by human peripheral blood lymphocytes publication-title: J Immunol – volume: 7 start-page: 213 year: 1990 end-page: 218 article-title: Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T‐lymphocyte subsets, and cells with natural killer markers publication-title: Am J Med Genet Suppl – volume: 147 start-page: 744 year: 2005 end-page: 747 article-title: Intrinsic abnormalities of lymphocyte counts in children with Down syndrome publication-title: J Pediatr – volume: 63 start-page: 108 year: 2011 end-page: 113 article-title: Collagenase‐2 (MMP‐8) as a point‐of‐care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non‐antimicrobial properties of tetracyclines publication-title: Pharmacol Res – volume: 9 start-page: 1473 year: 1995 end-page: 1481 article-title: Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids publication-title: FASEB J – volume: 1 start-page: 361 year: 1998 end-page: 366 article-title: The role of HIV‐1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review) publication-title: Int J Mol Med – volume: 7 start-page: 234 year: 1990 end-page: 237 article-title: Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes publication-title: Am J Med Genet Suppl – volume: 35 start-page: 7159 year: 1996 end-page: 7164 article-title: Selective regulation of RNK‐16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor publication-title: Biochemistry – volume: 167 start-page: 362 year: 2013 end-page: 368 article-title: The balance of serum matrix metalloproteinase‐8 and its tissue inhibitor in acute coronary syndrome and its recurrence publication-title: Int J Cardiol – volume: 24 start-page: 161 year: 1989 end-page: 164 article-title: Depressed helper‐to‐suppressor T‐cell ratios in early‐onset forms of periodontal disease publication-title: J Periodontal Res – volume: 164 start-page: 2102 year: 2000 end-page: 2109 article-title: Requirement of B7 costimulation for Th1‐mediated inflammatory bone resorption in experimental periodontal disease publication-title: J Immunol – volume: 57 start-page: 288 year: 1986 end-page: 293 article-title: The prevalence of periodontitis and dental caries in a Down's syndrome population publication-title: J Periodontol – volume: 156 start-page: 1 year: 1996 end-page: 4 article-title: Matrix metalloproteinases in immunity publication-title: J Immunol – volume: 160 start-page: 894 year: 2006 end-page: 899 article-title: Total body weight and waist circumference associated with chronic periodontitis among adolescents in the United States publication-title: Arch Pediatr Adolesc Med – volume: 149 start-page: 2506 year: 1992 end-page: 2512 article-title: Tumor necrosis factor‐alpha and IFN‐gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21) publication-title: J Immunol – volume: 115 start-page: 3719 year: 2002 end-page: 3727 article-title: Metalloproteinase inhibitors: biological actions and therapeutic opportunities publication-title: J Cell Sci – volume: 45 start-page: 170 year: 2010 end-page: 176 article-title: Analysis of matrix metalloproteinase (MMP‐8 and MMP‐2) activity in gingival crevicular fluid from children with Down's syndrome publication-title: J Periodontal Res – volume: 37 start-page: 233 year: 2010 end-page: 237 article-title: Analysis of peripheral blood T‐cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome publication-title: Int J Immunogenet – volume: 7 start-page: 204 year: 1990 end-page: 212 article-title: Immunology of Down syndrome: a review publication-title: Am J Med Genet Suppl – volume: 16 start-page: 300 year: 1989 end-page: 304 article-title: Criteria for assessment of interproximal bone loss on bite‐wing radiographs in adolescents publication-title: J Clin Periodontol – volume: 92 start-page: 827 year: 2003 end-page: 839 article-title: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry publication-title: Circ Res – volume: 67 start-page: 748 year: 1996 end-page: 754 article-title: Characterization of matrix metalloproteinase (MMP‐8 and ‐9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome publication-title: J Periodontol – volume: 13 start-page: 64 year: 1986 end-page: 73 article-title: Periodontal disease in Down's syndrome: a review publication-title: J Clin Periodontol – volume: 71 start-page: 1079 year: 2000 end-page: 1085 article-title: Collagen fibers and inflammatory cells in healthy and diseased human gingival tissues: a comparative and quantitative study by immunohistochemistry and automated image analysis publication-title: J Periodontol – volume: 103 start-page: 422 year: 1996 end-page: 428 article-title: Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues publication-title: Clin Exp Immunol – volume: 16 start-page: 267 year: 2012 end-page: 273 article-title: T‐helper‐related cytokines in gingival crevicular fluid from adolescents with Down syndrome publication-title: Clin Oral Investig – volume: 7 start-page: 244 year: 1992 end-page: 248 article-title: , and in subgingival plaque of adolescents with Down's syndrome publication-title: Oral Microbiol Immunol – volume: 48 start-page: 553 year: 2013 end-page: 562 article-title: Altered relationship between MMP‐8 and TIMP‐2 in gingival crevicular fluid in adolescents with Down's syndrome publication-title: J Periodontal Res – volume: 143 start-page: 256 year: 1959 end-page: 265 article-title: [Mongolism; a chromosomal disease (trisomy)] publication-title: Bull Acad Natl Med – volume: 41 start-page: 1 year: 1989 end-page: 4 article-title: [The immunological profile of children with Down's syndrome] publication-title: Minerva Pediatr – volume: 112 start-page: 1557 year: 2008 end-page: 1569 article-title: CD4 T cells: fates, functions, and faults publication-title: Blood – volume: 32 start-page: 684 year: 2005 end-page: 690 article-title: Periodontal conditions and subgingival microflora in Down syndrome patients. A case–control study publication-title: J Clin Periodontol – volume: 246 start-page: 143 year: 1987 end-page: 162 article-title: The immune system and susceptibility to infections in Down's syndrome publication-title: Prog Clin Biol Res – volume: 4 start-page: 243 year: 1980 end-page: 249 article-title: Phagocytic function in Down syndrome – I. Chemotaxis publication-title: J Ment Defic Res – volume: 34 start-page: 235 year: 1976 end-page: 249 article-title: Pathogenesis of inflammatory periodontal disease. A summary of current work publication-title: Lab Invest – volume: 69 start-page: 562 year: 2006 end-page: 573 article-title: Structure and function of matrix metalloproteinases and TIMPs publication-title: Cardiovasc Res – volume: 4 start-page: 251 year: 1980 end-page: 256 article-title: Phagocytic function in Down syndrome – II. Bactericidal activity and phagocytosis publication-title: J Ment Defic Res – volume: 38 start-page: 306 year: 2006 end-page: 321 article-title: Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation publication-title: Ann Med – ident: e_1_2_5_15_1 doi: 10.1902/jop.1996.67.8.748 – ident: e_1_2_5_11_1 doi: 10.1177/154405910608501202 – ident: e_1_2_5_21_1 doi: 10.1007/s00784-010-0495-6 – volume: 41 start-page: 1 year: 1989 ident: e_1_2_5_22_1 article-title: [The immunological profile of children with Down's syndrome] publication-title: Minerva Pediatr – ident: e_1_2_5_55_1 doi: 10.1111/j.1600-0757.1997.tb00195.x – ident: e_1_2_5_59_1 doi: 10.4049/jimmunol.164.4.2102 – volume: 156 start-page: 160 year: 1996 ident: e_1_2_5_37_1 article-title: Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane publication-title: J Immunol doi: 10.4049/jimmunol.156.1.160 – ident: e_1_2_5_48_1 doi: 10.1016/j.ijcard.2011.12.095 – ident: e_1_2_5_30_1 doi: 10.1007/s12026-009-8098-5 – ident: e_1_2_5_40_1 doi: 10.3109/00016359709115400 – volume: 4 start-page: 243 year: 1980 ident: e_1_2_5_16_1 article-title: Phagocytic function in Down syndrome – I. Chemotaxis publication-title: J Ment Defic Res – volume: 149 start-page: 2506 year: 1992 ident: e_1_2_5_19_1 article-title: Tumor necrosis factor‐alpha and IFN‐gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21) publication-title: J Immunol doi: 10.4049/jimmunol.149.7.2506 – volume: 4 start-page: 251 year: 1980 ident: e_1_2_5_17_1 article-title: Phagocytic function in Down syndrome – II. Bactericidal activity and phagocytosis publication-title: J Ment Defic Res – ident: e_1_2_5_52_1 doi: 10.1902/jop.2001.72.10.1398 – volume: 1 start-page: 361 year: 1998 ident: e_1_2_5_53_1 article-title: The role of HIV‐1 activated leukocyte adhesion mechanisms and matrix metalloproteinase secretion in AIDS pathogenesis (Review) publication-title: Int J Mol Med – ident: e_1_2_5_8_1 doi: 10.1161/01.RES.0000070112.80711.3D – ident: e_1_2_5_35_1 doi: 10.1096/fasebj.9.14.7589989 – ident: e_1_2_5_38_1 doi: 10.1016/0167-4889(93)90037-P – ident: e_1_2_5_43_1 doi: 10.1111/j.1600-051X.1989.tb01659.x – ident: e_1_2_5_13_1 doi: 10.1080/00016350310002270 – ident: e_1_2_5_7_1 doi: 10.1111/j.1399-302X.1992.tb00033.x – ident: e_1_2_5_25_1 doi: 10.1002/ajmg.1320370742 – ident: e_1_2_5_44_1 doi: 10.1902/jop.1986.57.5.288 – volume: 7 start-page: 234 year: 1990 ident: e_1_2_5_20_1 article-title: Decreased level of T cell receptor expression by Down syndrome (trisomy 21) thymocytes publication-title: Am J Med Genet Suppl – ident: e_1_2_5_42_1 doi: 10.1001/archpedi.160.9.894 – ident: e_1_2_5_57_1 doi: 10.1016/S0952-7915(98)80227-6 – ident: e_1_2_5_32_1 doi: 10.1111/j.1744-313X.2010.00914.x – ident: e_1_2_5_45_1 doi: 10.1080/00016350600963640 – volume: 6 start-page: 543 year: 1993 ident: e_1_2_5_31_1 article-title: Immunological features of Down's syndrome: a review publication-title: J Intellect Disabil Res doi: 10.1111/j.1365-2788.1993.tb00324.x – ident: e_1_2_5_61_1 doi: 10.1111/j.1600-0765.1989.tb02000.x – ident: e_1_2_5_9_1 doi: 10.1016/j.cardiores.2005.12.002 – volume: 98 start-page: 228 year: 1990 ident: e_1_2_5_3_1 article-title: Periodontal disease in children with Down's syndrome publication-title: Scand J Dent Res – ident: e_1_2_5_27_1 doi: 10.1016/j.jpeds.2005.07.022 – ident: e_1_2_5_46_1 doi: 10.1034/j.1600-0722.2002.21247.x – ident: e_1_2_5_41_1 doi: 10.1111/j.1600-051X.1993.tb00328.x – ident: e_1_2_5_49_1 doi: 10.1016/j.phrs.2010.10.005 – volume: 246 start-page: 143 year: 1987 ident: e_1_2_5_18_1 article-title: The immune system and susceptibility to infections in Down's syndrome publication-title: Prog Clin Biol Res – ident: e_1_2_5_12_1 doi: 10.1111/j.1600-0765.2009.01214.x – volume: 158 start-page: 2327 year: 1997 ident: e_1_2_5_34_1 article-title: Cytokine and chemokine regulation of proMMP‐9 and TIMP‐1 production by human peripheral blood lymphocytes publication-title: J Immunol doi: 10.4049/jimmunol.158.5.2327 – ident: e_1_2_5_6_1 doi: 10.1111/j.1600-051X.2005.00737.x – ident: e_1_2_5_58_1 doi: 10.1080/07853890600800103 – ident: e_1_2_5_14_1 doi: 10.1111/jre.12038 – ident: e_1_2_5_26_1 doi: 10.1016/S0361-9230(01)00476-2 – ident: e_1_2_5_50_1 doi: 10.1177/154405910708600509 – ident: e_1_2_5_4_1 doi: 10.1111/j.1651-2227.1995.tb13768.x – ident: e_1_2_5_5_1 doi: 10.1111/j.1600-051X.1986.tb01416.x – ident: e_1_2_5_28_1 doi: 10.1182/blood-2008-05-078154 – ident: e_1_2_5_29_1 doi: 10.1146/annurev.immunol.021908.132710 – ident: e_1_2_5_10_1 doi: 10.1242/jcs.00063 – ident: e_1_2_5_33_1 doi: 10.4049/jimmunol.156.1.1 – ident: e_1_2_5_56_1 doi: 10.1902/jop.2000.71.7.1079 – ident: e_1_2_5_36_1 doi: 10.1002/jcp.1041570326 – ident: e_1_2_5_24_1 doi: 10.1002/ajmg.1320370743 – ident: e_1_2_5_39_1 doi: 10.1021/bi960036x – volume: 34 start-page: 235 year: 1976 ident: e_1_2_5_54_1 article-title: Pathogenesis of inflammatory periodontal disease. A summary of current work publication-title: Lab Invest – ident: e_1_2_5_51_1 doi: 10.1111/j.1601-0825.2006.01323.x – ident: e_1_2_5_60_1 doi: 10.1111/j.1365-2249.1996.tb08297.x – volume: 55 start-page: 257 year: 1984 ident: e_1_2_5_23_1 article-title: Cell‐mediated immunodeficiency in Down's syndrome: normal IL‐2 production but inverted ratio of T cell subsets publication-title: Clin Exp Immunol – volume: 143 start-page: 256 year: 1959 ident: e_1_2_5_2_1 article-title: [Mongolism; a chromosomal disease (trisomy)] publication-title: Bull Acad Natl Med – ident: e_1_2_5_47_1 doi: 10.1016/j.phrs.2011.06.019 |
| SSID | ssj0002679 |
| Score | 2.1405199 |
| Snippet | Background and Objective
Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship... Altered immune response may be a major contributor to periodontal disease in Down syndrome. This study investigated the relationship between peripheral... |
| SourceID | swepub proquest pubmed crossref wiley istex |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 742 |
| SubjectTerms | Adolescent CD56 Antigen - analysis CD8 Antigens - analysis CD8-Positive T-Lymphocytes - immunology Child crevicular fluid Cross-Sectional Studies Down syndrome Down Syndrome - blood Down Syndrome - enzymology Down Syndrome - immunology Female Gingival Crevicular Fluid - enzymology Gingival Crevicular Fluid - immunology Gingivitis - blood Gingivitis - enzymology Gingivitis - immunology Humans Killer Cells, Natural - immunology Lipopolysaccharides - pharmacology Male Matrix Metalloproteinase 3 - blood Matrix Metalloproteinase 8 - blood Matrix Metalloproteinase 9 - blood matrix metalloproteinases Pilot Projects Porphyromonas gingivalis serum T cells Tissue Inhibitor of Metalloproteinase-1 - blood Tissue Inhibitor of Metalloproteinase-2 - blood Tissue Inhibitor of Metalloproteinase-3 - blood Young Adult |
| Title | The relationship between matrix metalloproteinases (MMP-3, -8, -9) in serum and peripheral lymphocytes (CD8+, CD56+) in Down syndrome children with gingivitis |
| URI | https://api.istex.fr/ark:/67375/WNG-3M3VXFH0-Z/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjre.12157 https://www.ncbi.nlm.nih.gov/pubmed/24372339 https://www.proquest.com/docview/1622064132 https://www.proquest.com/docview/1654684570 http://kipublications.ki.se/Default.aspx?queryparsed=id:130160255 |
| Volume | 49 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1600-0765 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002679 issn: 0022-3484 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1baxQxFA5tV9AX75f1UqKIVNqBmSQzmeCT7HQt4i6lWF18CUkmg0t3Z8vsrrZv_gR_hL_MX-JJ5oKFKoIvQ5g5YXL5TnKSnHwHoecmz4VSVgTUpDpgiWaBSEURWJj9ch5HCSnqYBN8PE4nE3G4gV61d2Fqfohuw81phh-vnYIrvfxdySvrqRH4Juq5S1Ww8uplR8Pjd91ATBIuOrJwlrKGWMg78rSZL0xHPdeyZ5fZmh2R6EUb1k9Cwxv_Vfyb6Hpje-LXNVhuoQ1b3kZXM-cv5EK-3UE_ADS4at3jPk9PcePGheeOyf8Mz-3KHdR7codpCRPgEu-MRoc_v32nexieqX-Kl3haYsD2eo5VmWNHpuzZC2Z4dg7oWZjzlcs5yNLdPTzI4mTX58gWXyFbQ6GA22vm2G0VYxdLycW5mC7vouPh_vvBQdCEcQgMZYIHUF-RqyTJI16AsaRynXNNtAnjnNjQ6kLHqVYmcmSAiRHGxpZoTrkpRMJ0ZOg9tFUuSvsAYWIYAwtThUobRpQRJKYFKdKIFSGNLe2jnbY3pWk4zl2ojZns1jqVlb7Z--hZJ3paE3tcJvTCQ6KTUNWJ84Tjsfw4fiPpiH6YDA9C-amPnraYkaCf7tBFlXaxXkpAOwGzDxb9f5OBmqcs5mEf3a8B1_3REUYSSgUUpUZg98URgzevTiBlZUzA0nBt4HH351rJt0f7PvHw30UfoWtgKrLakecx2lpVa_sEXTFfoN-rbbTJJ-l2o3-_AB5LNQo |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZGi7S9cL-Uq0EIDW2REtuJbYkX1K4UaKtp2qDixbIdR6vWplPawvbGT-BH8Mv4JdjORUwaCIkXy0qOFdv5jn1sH38HgBc6TbmUhgdYMxWQRJGAM54Fxs5-KY2jBGVlsAk6HrPJhO9vgNf1XZiSH6LZcHOa4cdrp-BuQ_p3LS-M50agV0CbJJiyFmj3DvpHw2YkRgnlDVs4YaRiFvKePHXhC_NR23Xt2WXGZsMketGI9bNQ__r_1f8GuFZZn_BNCZebYMPkt8Bmz3kMuaBvt8EPCxtY1A5yx9NTWDlywbnj8j-Dc7NyR_We3mGa2ylwCbdHo_2f377jXWhT5lP-Ck5zaNG9nkOZp9DRKXv-ghmcnVv8LPT5ypXs9tjOLuz24mTHl-gtvtpiFYkCrC-aQ7dZDF00JRfpYrq8A476e4fdQVAFcgg0JpwGtr08lUmSRjSz5pJMVUoVUjqMU2RCozIVMyV15OgAE821iQ1SFFOd8YSoSOO7oJUvcnMfQKQJsTamDKXSBEnNUYwzlLGIZCGODe6A7fp3Cl2xnLtgGzPRrHYKI3y3d8DzRvS0pPa4TOilx0QjIYsT5wtHY_Fp_FbgEf446Q9C8bkDntWgEVZD3bGLzM1ivRQW78gafnbZ_zcZ23JGYhp2wL0Scc0XHWUkwpjbqpQQbN44avDq0YnNGREja2u4PvDA-3OrxPuDPZ958O-iT8Hm4HA0FMN34w8PwZY1HEnp1vMItFbF2jwGV_UXi4HiSaWGvwA7HTgS |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLZGixgv3AflahBCQ1uk1Jc4lnhBzcqAtaomNipeLNtxRLU2rdIWtjd-Aj-CX8YvwXYuYtJASLxYVnKs2M537GP7-DsAPNdpyqU0PMA6VgGJFAl4zLPA2NkvZbQboawMNsGGw3g85qMN8Kq-C1PyQzQbbk4z_HjtFNws0ux3LS-M50Zgl0CbUE5JC7STw_7RQTMSo4jxhi2cxKRiFvKePHXhc_NR23Xt6UXGZsMket6I9bNQ__r_1f8GuFZZn_B1CZebYMPkt8Bm4jyGXNC32-CHhQ0sage5z5MFrBy54Mxx-Z_CmVm5o3pP7zDJ7RS4hNuDwejnt-94F9o09il_CSc5tOhez6DMU-jolD1_wRROzyx-5vps5Ur2knhnF_YSGu34Esn8qy1WkSjA-qI5dJvF0EVTcpEuJss74Ki_96G3H1SBHAKNCWeBbS9PZRSlXZZZc0mmKmUKKR3SFJnQqEzRWEnddXSAkebaUIMUw0xnPCKqq_EWaOXz3NwDEGlCrI0pQ6k0QVJzRHGGsrhLshBTgztgu_6dQlcs5y7YxlQ0q53CCN_tHfCsEV2U1B4XCb3wmGgkZHHifOEYFR-HbwQe4ONxfz8UnzrgaQ0aYTXUHbvI3MzXS2HxjqzhZ5f9f5OxLY8JZWEH3C0R13zRUUYijLmtSgnB5o2jBq8endicERRZW8P1gQfen1sl3h3u-cz9fxd9Aq6Mkr44eDt8_wBctXYjKb16HoLWqlibR-Cy_mIhUDyutPAXdjw3jQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relationship+between+matrix+metalloproteinases+%28MMP-3%2C-8%2C-9%29+in+serum+and+peripheral+lymphocytes+%28CD8+%2B+%2C+CD56+%2B+%29+in+Down+syndrome+children+with+gingivitis&rft.jtitle=Journal+of+periodontal+research&rft.au=Tsilingaridis%2C+G&rft.au=Yucel-Lindberg%2C+T&rft.au=Quezada%2C+HC&rft.au=Modeer%2C+T&rft.date=2014-12-01&rft.issn=0022-3484&rft.volume=49&rft.issue=6&rft.spage=742&rft_id=info:doi/10.1111%2Fjre.12157&rft.externalDocID=oai_swepub_ki_se_524713 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3484&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3484&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3484&client=summon |